DiaMedica Therapeutics (DMAC) EBITDA (2018 - 2026)
DiaMedica Therapeutics' EBITDA came in at -$10.49 million for Q2 2026, compared with -$8 million a year earlier.
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) EBITDA (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, DiaMedica Therapeutics reported EBITDA of -$39.17 million; for FY2025, it was -$34.35 million.
- Going back by year, EBITDA was -$26.64 million in FY2024, -$21.24 million in FY2023, -$13.98 million in FY2022 and -$13.62 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly EBITDA in data going back to Q1 2018.
- Business Quant data shows DMAC's EBITDA at -$10.47 million (Q1 2026), -$9.2 million (Q4 2025) and -$9.02 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.30 Bn |
| 10 | DiaMedica Therapeutics | 445.97 Mn | 445.97 Mn | - | -10.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.49 Mn |
| Mar 31, 2026 | -10.47 Mn |
| Dec 31, 2025 | -9.20 Mn |
| Sep 30, 2025 | -9.02 Mn |
| Jun 30, 2025 | -8.00 Mn |
| Mar 31, 2025 | -8.13 Mn |
| Dec 31, 2024 | -8.41 Mn |
| Sep 30, 2024 | -6.87 Mn |
| Jun 30, 2024 | -5.63 Mn |
| Mar 31, 2024 | -5.73 Mn |
| Dec 31, 2023 | -5.84 Mn |
| Sep 30, 2023 | -5.15 Mn |
| Jun 30, 2023 | -4.73 Mn |
| Mar 31, 2023 | -5.51 Mn |
| Dec 31, 2022 | -3.97 Mn |
| Sep 30, 2022 | -3.12 Mn |
| Jun 30, 2022 | -3.36 Mn |
| Mar 31, 2022 | -3.53 Mn |
| Dec 31, 2021 | -3.24 Mn |
| Sep 30, 2021 | -3.41 Mn |
API Access
DiaMedica Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=DMAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "DMAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=DMAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();